Institution statistics

ST GEORGE'S HOSPITAL MEDICAL SCHOOL - United Kingdom 

Ranking results:

Past rankings:
2016
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2015
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2014
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2012
Criterium:Position:
Overall Score:600-700
Total Project Funding:> 1000
Total Project Funding per Partner:600-700
Total Number of Projects:68
Networking Rank (Reputation):> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:46
Project Leadership Index:73
Diversity Index:60
2011
Criterium:Position:
Overall Score:500-600
Total Project Funding:200-300
Total Project Funding per Partner:200-300
Total Number of Projects:600-700
Networking Rank (Reputation):600-700
Partner Constancy:700-800
Project Leadership Index:400-500
Diversity Index:> 1000
2010
Criterium:Position:
Overall Score:300-400
Total Project Funding:100-200
Total Project Funding per Partner:200-300
Total Number of Projects:200-300
Networking Rank (Reputation):100-200
Partner Constancy:500-600
Project Leadership Index:300-400
Diversity Index:> 1000
2009
Criterium:Position:
Overall Score:300-400
Total Project Funding:900-1000
Total Project Funding per Partner:600-700
Total Number of Projects:500-600
Networking Rank (Reputation):900-1000
Partner Constancy:600-700
Project Leadership Index:300-400
Diversity Index:500-600
2008
Criterium:Position:
Overall Score:> 1000
Total Project Funding:200-300
Total Project Funding per Partner:300-400
Total Number of Projects:500-600
Networking Rank (Reputation):600-700
Partner Constancy:700-800
Project Leadership Index:700-800
Diversity Index:> 1000
2007
Criterium:Position:
Overall Score:300-400
Total Project Funding:100-200
Total Project Funding per Partner:200-300
Total Number of Projects:300-400
Networking Rank (Reputation):300-400
Partner Constancy:500-600
Project Leadership Index:200-300
Diversity Index:> 1000
Ranking timeline:

European project participation (2000-01-01 - 2018-12-31 ):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:
Leadership:

Total number of projects: 71
As coordinator: 10
As participant: 59
Sole participant: 2
Coordinator / Participant Ratio: 0.17*

*Ratio includes only projects with > 2 partners

Summary:
Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2018 0 7.199.560 562.823 1
2017 8.286.009 4.337.475 2.233.385 1 1
2016 0 2.348.803 255.880 1
2015 7.993.660 6.574.963 2.951.018 1 2
2014 0 7.492.000 950.244 2
2013 0 5.998.496 198.242 1
2012 4.053.050 4.976.953 1.453.957 2 2
2011 0 55.458.695 3.934.795 4
2010 11.997.333 46.275.222 2.476.319 1 8
2009 1.754.774 8.828.621 1.060.390 1 3
2008 0 40.354.451 2.595.786 5
2007 20.095.505 4.846.226 1.044.397 1 3
2006 0 47.494.633 2.695.520 7
2005 85.533 20.525.999 1.060.463 1 3
2004 0 42.968.897 1.751.854 6
2003 0 15.550.000 518.333 1
2002 1.801.301 3.192.825 648.149 2 2
2001 880.149 4.207.528 1.060.172 1 3
2000 114.272 6.105.798 844.256 1 4
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:
Institution:Projects [No]:
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE14
KAROLINSKA INSTITUTE12
UNIVERSITY COLLEGE LONDON11
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE10
INSTITUT PASTEUR10
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE9
KING'S COLLEGE LONDON8
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD8
UNIVERSITA DEGLI STUDI DI SIENA8
FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR7
ISTITUTO SUPERIORE DI SANITA7
CHARITE UNIVERSITAETSMEDIZIN BERLIN6
COMMISSARIAT A L'ENERGIE ATOMIQUE6
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM6
KATHOLIEKE UNIVERSITEIT LEUVEN6
LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE6
STATENS SERUM INSTITUT6
STICHTING KATHOLIEKE UNIVERSITEIT6
CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS5
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V5
MEDICAL RESEARCH COUNCIL5
POLYMUN SCIENTIFIC IMMUNBIOLOGISCHE FORSCHUNG5
UNIVERSITY OF BIRMINGHAM5
UNIVERSITY OF SURREY5
CONSIGLIO NAZIONALE DELLE RICERCHE4
COUNCIL FOR SCIENTIFIC AND INDUSTRIAL RESEARCH4
DEPARTMENT OF HEALTH4
MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN EV4
OSPEDALE PEDIATRICO BAMBINO GESU4
PRINS LEOPOLD INSTITUUT VOOR TROPISCHE GENEESKUNDE4
STICHTING DIENST LANDBOUWKUNDIG ONDERZOEK4
THE QUEEN'S UNIVERSITY OF BELFAST4
THE UNIVERSITY OF LIVERPOOL4
UNIVERSITA DEGLI STUDI DI MILANO4
UNIVERSITE DE GENEVE4
UNIVERSITEIT UTRECHT4
UNIVERSITY OF YORK4
UNIVERSITY OF ZURICH4
ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM3
ACADEMISCH ZIEKENHUIS GRONINGEN3
ARISTOTLE UNIVERSITY OF THESSALONIKI3
BERNHARD NOCHT INSTITUT FUER TROPENMEDIZIN3
CONSORZIO PER VALUTAZIONI BIOLOGICHE E FARMACOLOGICHE3
FONDAZIONE PENTAFOR THE TREATMENT AND CARE OF CHILDREN WITH HIVONLUS3
GLAXOSMITHKLINE BIOLOGICALS3
GoeTEBORG UNIVERSITY3
INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE3
JOHN INNES CENTRE3
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN3
RHEINISCH WESTFAELISCHE TECHNISCHE HOCHSCHULE AACHEN3
SERVICIO MADRILENO DE SALUD3
SOUTH AFRICAN MEDICAL RESEARCH COUNCIL3
SYNAPSE RESEARCH MANAGEMENT PARTNERS SL3
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE3
UNIVERSITA DEGLI STUDI DI VERONA3
UNIVERSITE PIERRE ET MARIE CURIE PARIS VI3
UNIVERSITY OF AARHUS3
UNIVERSITY OF GLASGOW3
UNIVERSITY OF NEWCASTLE UPON TYNE3
VTT TECHNICAL RESEARCH CENTRE OF FINLAND3
WORLD HEALTH ORGANIZATION3
ACADEMISCH ZIEKENHUIS BIJ DE UNIVERSITEIT VAN AMSTERDAM2
AGENCE FRANCAISE DE SECURITE SANITAIRE DES ALIMENTS2
AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS2
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS2
ASTRAZENECA AB2
CENTRE D'ETUDE ET DE RECHERCHES VETERINAIRES ET AGROCHIMIQUES2
ENTE PER LE NUOVE TECNOLOGIE L'ENERGIA E L'AMBIENTE2
EUROPEAN AIDS TREATMENT GROUP EV2
EUROPEAN RESEARCH AND PROJECT OFFICE2
FOUNDATION FOR RESEARCH AND TECHNOLOGY HELLAS2
FUNDACIO INSTITUT DE INVESTIGACIO EN CIENCIES DE LA SALUT GERMANS TRIAS I PUJOL2
GENEART2
GENOME RESEARCH2
GOETEBORGS UNIVERSITET2
GREENOVATION BIOTECH2
GSF FORSCHUNGSZENTRUM FUER UMWELT UND GESUNDHEIT2
HEALTH PROTECTION AGENCY2
HELSINKI UNIVERSITY CENTRAL HOSPITAL2
HOOKIPA BIOTECH2
INSTITUTO DE SALUD CARLOS III2
INSTITUTO NACIONAL DE SAUDE2
ISLENSK ERFDAGREINING EHF2
ISTITUTO NAZIONALE PER LO STUDIO E LA CURA DEI TUMORI2
LEIDEN UNIVERSITY2
LIONEX2
LIONEX DIAGNOSTICS & THERAPEUTICS2
LIVERPOOL SCHOOL OF TROPICAL MEDICINE2
LUND UNIVERSITY2
MEDIZINISCHE UNIVERSITAET WIEN2
MEDIZINISCHE UNIVERSITAT GRAZ2
MICROBIOTEC2
MOREDUN RESEARCH INSTITUTE2
NATIONAL BIOLOGICAL STANDARDS BOARD2
NATIONAL RESEARCH COUNCIL OF ITALY2
NATIONAL VETERINARY INSTITUTE2
NEED PHARMACEUTICALS2
QUEEN MARY AND WESTFIELD COLLEGE UNIVERSITY OF LONDON2
RIJKSINSTITUUT VOOR VOLKSGEZONDHEID EN MILIEU2
ROBERT KOCH INSTITUT2
Constancy:

Total number of partners:963

Partner loyalty:
Frequent Partner: (> 2 projects): 301
Rare Partner: 662

Frequent / Rare Partner Ratio: 0.45

Diversity:

Categories:
Category:No:
BIOLOGICAL SCIENCES51
RTD HORIZONTAL TOPICS24
SOCIAL AND ECONOMIC CONCERNS21
PROTECTING MAN AND HIS ENVIRON8
AGRICULTURE AND MARINE RESOURC4
INDUSTRY AND TECHNOLOGY2

Project overview:

Start dateProjectacronymrolefundingpartners
2018-01-01Developing Multipurpose Nicotiana Crops for Molecular Farming using New Plant Breeding Techniques Newcotianaparticipant7.199.56019
2017-11-01Building the product pipeline for commercial demonstration of Plant Molecular Factories Pharma-Factorycoordinator8.286.00914
2017-04-01Integration and analysis of heterogeneous big data for precision medicine and suggested treatments for different types of patients IASISparticipant4.337.47510
2016-01-01Understanding asthma phenotypes: going beyond the atopic/non-atopic paradigm AsthmaPhenotypesparticipant2.348.8036
2015-11-01Multidisciplinary tools for improving the efficacy of public prevention measures against smoking SmokeFreeBrainparticipant2.981.00115
2015-09-01Advanced nanophotonic point-of-care analysis device for fast and early diagnosis of cardiovascular diseases PHOCNOSISparticipant3.593.96211
2015-01-01Eliciting Mucosal Immunity to Tuberculosis EMI-TBcoordinator7.993.66014
2014-02-01Treatment of late onset bacterial sepsis caused by vancomycin susceptible bacteria in neonates and infants aged under three months NEOVANCparticipant5.993.00012
2014-01-01Semantic Data Platform for Healthcare SEMCAREparticipant1.499.0005
2013-02-01"Concurrent Tuberculosis and Diabetes Mellitus; unraveling the causal link, and improving care" TANDEMparticipant5.998.49612
2012-07-01Development of a handheld antimalarial drug resistance diagnostic device using nanowire technology NANOMALcoordinator3.992.1504
2012-04-01Knowledge exchange in processing and analysis of multi-omic data KEPAMODcoordinator60.9004
2012-01-01NCDs and their social determinants in Mediterranean partner countries: building sustainable research capacity for effective policy intervention RESCAP-MEDparticipant1.986.25512
2012-01-01A stealth attack tool for preventing clinical drug resistance through a unique self-regenerating surface BacAttackparticipant2.990.6987
2011-12-01Targeting Brain Inflammation For Improved Functional Recovery in Acute Neurodegenerative Disorders TargetBraInparticipant11.989.16210
2011-10-01Advanced Immunization Technologies ADITECparticipant29.980.67052
2011-08-01Exploiting plants for the production of future generation recombinant pharmaceuticals Future-Pharmaparticipant3.488.8632
2011-01-01Global Research in Paediatrics GRiPparticipant10.000.00023
2010-12-01Easy and rapid generation of light-emitting somatic-transgenic mice to monitor specific disease states and to screen effective drugs SomaBioparticipant1.471.2723
2010-11-01The European Network for Translational Research in Atrial Fibrillation EUTRAFcoordinator11.997.33320
2010-08-01Multicentre discovery of breast cancer biomarkers CANOMICSparticipant86.4003
2010-03-01Identification and development of vaccine candidates for Buruli Ulcer Disease BuruliVacparticipant4.599.98316
2010-03-01TRANSLATIONAL RESEARCH AND PATIENT SAFETY IN EUROPE TRANSFoRmparticipant7.540.00025
2010-01-01Cutaneous and Mucosal HIV Vaccination CUT'HIVACparticipant11.929.25018
2010-01-01Arrhythmogenic potential of drugs ARITMOparticipant2.748.31920
2010-01-01Combined Highly Active Anti-retroviral Microbicides CHAARMparticipant11.999.99834
2010-01-01European multicenter network to evaluate pharmacokinetics, safety and efficacy of Meropenem in neonatal sepsis and meningitis NEOMEROparticipant5.900.00012
2009-10-01Access to Pharmaceuticals ATPcoordinator1.754.7745
2009-06-01Contained molecular farming controllable contained systems for high yield and consistency COMOFARMparticipant2.834.79710
2009-02-01Signalling in life cycle stages of malaria parasites MALSIGparticipant3.000.00017
2009-01-01Preventing community and nosocomial spread and infection with MRSA ST 398 - instruments for accelerated control and integrated risk management of antimicrobial resistance PILGRIMparticipant2.993.82412
2008-10-01Intervention strategies against malaria INTERMALTRAININGparticipant2.982.25013
2008-07-01Fighting aneurysmal diseases FADparticipant10.998.93615
2008-05-01European Collaborative Project on Inflamation and Vascular Wall Remodelling in Atherosclerosis ATHEROREMOparticipant11.691.18019
2008-02-01Latent tuberculosis: new tools for the detection and clearance of dormant mycobacterium tuberculosis STOPLATENT-TBparticipant2.716.0037
2008-01-01EUROpean consortium on NEUTralising antibodies using gp41 EURONEUT-41participant11.966.08219
2007-04-01SME-led antibody glyco-engineering SAGEparticipant1.842.9279
2007-03-01Development of a European measure of best practice for people with long term mental illness in institutional care DEMOB.INCparticipant1.497.59711
2007-01-01European vaccine and microbicides enterprise EUROPRISEcoordinator20.095.50539
2007-01-01Mucosal nano vaccine candidate for HIV MUNANOVACparticipant1.505.7028
2006-09-01Galway laboratory for biomedical data mining BIOMED MINEparticipant513.6725
2006-06-01Development of improved tools for detection of paratuberculosis in livestock, M.paratuberculosis in food and for the assessment of the risk of human exposure PARATBTOOLSparticipant3.940.00028
2006-03-01A multidisciplinary study to identify the genetic and environmental causes of asthma in the European Community GABRIELparticipant11.327.58537
2006-01-01Recombinant measles virus as a vector for HIV vaccines RMVHIVparticipant5.499.3246
2006-01-01New medicines for tuberculosis NM4TBparticipant11.070.00022
2006-01-01Systems biology of nuclear receptors: A nutrigenomics approach to aging-related diseases NUCSYSparticipant3.744.05418
2006-01-01Heart Failure and Repair HEARTREPAIRparticipant11.399.99822
2005-12-01Development of New Drugs for the Treatment of Malaria ANTIMALparticipant17.750.00037
2005-09-01New drugs for persistent tuberculosis: Exploitation of 3-D structure of novel targets, lead optimisation and functional in-vivo evaluation NEWTBDRUGSparticipant1.800.0006
2005-04-07GENERATION OF NEW ANTI-RABIES ANTIBODIES FOR POST EXPOSURE PROPHYLAXIS AND PRODUCTION IN PLANTS. PLANTIRABIEScoordinator85.5331

overview shows latest 50 from 71 projects (2000-01-01 - 2018-12-31)
A full list of projects can be found here:

Alias institution names:
  • ST GEORGE'S HOSPITAL MEDICAL SCHOOL
  • ST GEORGE'S HOSPITAL MEDICAL SCHOOL UNIVERSITY OF LONDON
  • ST GEORGE'S HOSPITAL MEDICAL SCHOOL'
  • ST GEORGE'S UNIVERSITY OF LONDON
  • ST GEORGE'S UNIVERSITY OF LONDON (PREV: ST GEORGE'S HOSPITAL MEDICAL SCHOOL)
  • ST GEORGES HOSPITAL MEDICAL SCHOOL

Data provision: © European Union; Source: CORDIS, http://cordis.europa.eu/ | This page is not provided by the European Commission see:Impressum
Ads: